Information:
Error:
ID
34399
Description
Dimethyldiguanide Combined With Aromatase Inhibitor (AI) in Metastatic Breast Cancer; ODM derived from: https://clinicaltrials.gov/show/NCT01654185
Link
https://clinicaltrials.gov/show/NCT01654185
Keywords
Versions (1)
- 1/17/19 1/17/19 -
Copyright Holder
see on clinicaltrials.gov
Uploaded on
January 17, 2019
DOI
To request one please log in.
License
Creative Commons BY 4.0
Model comments :
You can comment on the data model here. Via the speech bubbles at the itemgroups and items you can add comments to those specificially.
Itemgroup comments for :
Item comments for :
In order to download data models you must be logged in. Please log in or register for free.
Eligibility Metastatic Breast Cancer NCT01654185
Eligibility Metastatic Breast Cancer NCT01654185
- StudyEvent: Eligibility
Similar models
Eligibility Metastatic Breast Cancer NCT01654185
- StudyEvent: Eligibility
Name
Type
Description | Question | Decode (Coded Value)
Data type
Alias
ID.1
Item
postmenopausal hr positive breast cancer patients;
boolean
ID.2
Item
inoperable locally advanced or metastatic breast cancer patients;
boolean
ID.3
Item
candidate for endocrine therapy;
boolean
ID.4
Item
ecog equal to or less than 1;
boolean
ID.5
Item
adequate bone marrow function(hb>=90g/l, wbc >=3.5×10^9/l,anc>=1.5×10^9/l, plt>=80×10^9/l; adequate renal function(ccr<=uln);adequate liver function(alt,ast,akp<=2.5*uln,or <=5*uln if liver metastases)
boolean
ID.6
Item
life expectancy >=12weeks;
boolean
ID.7
Item
no severe history disease of liver,heart,lung or kidney;
boolean
ID.8
Item
written informed consent form;
boolean
ID.9
Item
her-2 overexpression;
boolean
ID.10
Item
patients who has visceral endocrisis；
boolean